Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Medicine, Renal cell carcinoma, Sunitinib, Pazopanib, Internal medicine, and Oncology.
1523P Gut microbiome composition associates with clinical response to immune checkpoint inhibitor (ICI) therapy across multiple patient cohorts
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)
Dynamic biomarker and imaging changes from a phase II study of pre‐ and post‐surgical sunitinib
Identification of a microbiome signature predicting immune checkpoint inhibitor outcomes across multiple cancer types in the MITRE study.
Selection of Oncogenic Mutant Clones in Normal Human Skin Varies with Body Site
A phase II clinical study evaluating the efficacy and safety of neoadjuvant and adjuvant sunitinib in previously untreated patients with metastatic renal cell carcinoma (mRCC)(NeoSun).
Survival trends of renal cell cancer patients treated with neoadjuvant tyrosine kinase inhibitors before cytoreductive nephrectomies
<scp>B</scp>ritish <scp>HIV</scp> Association guidelines for <scp>HIV</scp>‐associated malignancies 2014
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
Randomized, Open-Label, Phase III Trial Of Pazopanib Versus Sunitinib In First-Line Treatment Of Patients With Metastatic Renal Cell Carcinoma (MRCC): Results of the Comparz Trial